Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gravina

Showing results (1031-1040 of 1,077) with videos related to

Pageof 108
Sort By:
The Lancet. Oncology|November 12, 2022
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, Francesca Poggio, Eva Blondeaux, et al.
The Lancet. Oncology|February 28, 2018
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trialSabino De Placido, Ciro Gallo, Michelino De Laurentiis, et al.
International Journal of Cardiology|November 15, 2025
Focal Takotsubo syndrome: Clinical features and outcomesFrancesco Santoro, Luca Arcari, Iván J Núñez Gil, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
Châtelperronian cultural diversity at its western limits: Shell beads and pigments from La Roche-à-Pierrot, Saint-CésaireFrançois Bachellerie, Brad Gravina, Solange Rigaud, et al.
Science (New York, N.Y.)|August 31, 2019
<i>Maleness-on-the-Y</i> (<i>MoY</i>) orchestrates male sex determination in major agricultural fruit fly pestsAngela Meccariello, Marco Salvemini, Pasquale Primo, et al.
Cancers|March 13, 2025
Epidemiology of Thyroid Cancer in Tuscany (Central Italy) 2013-2017: Not Just OverdiagnosisMarco Capezzone, Liborio Torregrossa, Anello Marcello Poma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE studyF Nuzzo, C Gallo, S Lastoria, et al.
Plos One|October 12, 2022
Yield of soybean genotypes identified through GGE biplot and path analysisWelder José Dos Santos Silva, Francisco de Alcântara Neto, Wahidah H Al-Qahtani, et al.
Pageof 108

Showing results (1031-1040 of 1,077) with videos related to

Sort By:
Pageof 108
The Lancet. Oncology|November 12, 2022
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, Francesca Poggio, Eva Blondeaux, et al.
The Lancet. Oncology|February 28, 2018
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trialSabino De Placido, Ciro Gallo, Michelino De Laurentiis, et al.
International Journal of Cardiology|November 15, 2025
Focal Takotsubo syndrome: Clinical features and outcomesFrancesco Santoro, Luca Arcari, Iván J Núñez Gil, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
Châtelperronian cultural diversity at its western limits: Shell beads and pigments from La Roche-à-Pierrot, Saint-CésaireFrançois Bachellerie, Brad Gravina, Solange Rigaud, et al.
Science (New York, N.Y.)|August 31, 2019
<i>Maleness-on-the-Y</i> (<i>MoY</i>) orchestrates male sex determination in major agricultural fruit fly pestsAngela Meccariello, Marco Salvemini, Pasquale Primo, et al.
Cancers|March 13, 2025
Epidemiology of Thyroid Cancer in Tuscany (Central Italy) 2013-2017: Not Just OverdiagnosisMarco Capezzone, Liborio Torregrossa, Anello Marcello Poma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE studyF Nuzzo, C Gallo, S Lastoria, et al.
Plos One|October 12, 2022
Yield of soybean genotypes identified through GGE biplot and path analysisWelder José Dos Santos Silva, Francisco de Alcântara Neto, Wahidah H Al-Qahtani, et al.
Pageof 108